     
Mailing
List
Contact
Us
Staff
|
 |
Aram
Chobanian, BU president ad interim, stresses unity, forward movement
By
Brian Fitzgerald
 |

|
|
Aram Chobanian Photo by Vernon Doucette
|
|
 |
Calling Aram Chobanian an effective and proven administrator, colleagues
from both the Charles River Campus and the Medical Campus praised his
selection as president ad interim by the BU Board of Trustees. The Medical
Campus provost will lead the University while it undertakes the process
of hiring a new president. The Board named Chobanian, who has been dean
of the School of Medicine since 1988, to the post on October 31.
BU and
Daniel Goldin, who was slated to take office on November 1, reached a
mutual agreement last week that he would not assume the presidency.
At
a meeting of the full Board on October 31, the Trustees also voted to
appoint an ad hoc Committee on Governance to consider issues relating
to Board structure, composition, and organization. “The committee
will also define the search process for the next BU president,” says
Dexter Dodge (SMG’56), Board vice chairman. He adds that despite
the media spotlight on BU in the past couple of weeks, he doesn’t
think the controversy will diminish the University’s reputation.
Chobanian
says that his priorities go beyond simply helping the University through
a healing process. “I want to get the institution moving
ahead, as it has done in the past,” he says. “I’m not
someone who just sits still. I think the healing part will happen, and
it will happen quickly as we reach out and communicate with our different
constituencies. I’m in full swing, looking at what needs to be
done to continue the University’s forward movement.”
“ Dr. Chobanian is highly regarded in the medical community, not only in
Boston, but all over the country,” says MED Associate Dean Barry Manuel. “He
has made outstanding contributions in the area of cardiovascular disease. As
an administrator, his strongest quality is his integrity and leadership ability.
His people skills are excellent and will help him transition smoothly into his
new position. He has all the traits that excellent leadership requires.”
“
We are delighted that Dr. Chobanian has agreed to assume the role of president
ad interim of Boston University during this transition period,” says Trustee
Chairman Christopher Barreca (DGE’50, LAW’53). “The Board has
full confidence in his ability as a leader, a teacher, and a bridge-builder.”
Norman
Levinsky, associate provost of the Medical Campus, says that Chobanian’s
reputation in academic medicine is evident in his selection as chair of the Joint
Committee on Detection, Evaluation, and Treatment of Hypertension, a prestigious
national group that makes recommendations on the management of high blood pressure
to American physicians. Levinsky also points to Chobanian’s “impressive
achievements during his tenure as dean and provost, including the recruitment
of outstanding new chairs, expanding the funding and laboratory space for research,
and personal attention to students.”
Underlying Chobanian’s achievements
is “a calm, thoughtful manner
in dealing with all categories of people,” says Levinsky. “This skill,
together with his high intelligence, should serve him and BU well in his new
position.”
Faculty Council Chairman Herbert Voigt, an ENG biomedical engineering
professor,
says that Chobanian is also a “fabulous fundraiser and a warm colleague,
with many ties to the faculty from which he emerged.” Chobanian met with
members of the Faculty Council leadership and four members of the Board of Trustees
on November 3, Voigt says, and “he has committed to improving the communication
channels between faculty and the Board. He is forward-looking and I believe he
will be a wonderful leader for Boston University.”
School of Management
Dean Louis Lataif says that as well as an “impeccable” reputation,
Chobanian “has a very compassionate, collaborative style of leadership
that is a great strength. But he is also steadfast in his convictions. Both temperamentally
and intellectually, he’s an outstanding choice to lead the University through
this transition period.”
It’s difficult to quickly pinpoint and sum
up his leadership style, Chobanian
says, but “I’m one who utilizes all the talents that are available
to build, and that includes faculty and students. I’ve had regular meetings
with students on the Medical Campus, and I’ve had very good relationships
with the faculty there. I’ve not had as much interaction, obviously, with
faculty and students on the Charles River Campus, but I think these kind of relationships
have helped me a good deal in building a great Medical Campus, and will serve
the entire University well in the future.”
Chobanian, a MED faculty member
for 40 years, and Medical Campus provost for the past 7, has overseen major curriculum
revisions and departmental organizations,
and created three new departments: emergency medicine, family medicine, and genetics.
Under his leadership, research funding has almost tripled, to about $160 million
for the School of Medicine and about $250 million for the entire Medical Campus.
During
his administration, the BioSquare Research Park has been developed on the Medical
Campus, and on September 30 the BU Medical Center was awarded a federal
grant of approximately $120 million to build a National Biocontainment Laboratory.
He also played an important part in unifying the Medical Campus during the 1996
merger between the former Boston City Hospital and Boston University Medical
Center Hospital. Clinical departments and services were combined, creating Boston
Medical Center.
Chobanian’s role in the merger, which ensured that thousands
of poor and uninsured patients in Boston would continue to receive first-rate
health care,
was lauded by Elaine Ullian, president and CEO of Boston Medical Center. She
also points out his subsequent recruitment of top doctors from around the country
to the facility, which is the primary teaching affiliate of the BU School of
Medicine.
“
He has a warm and engaging style,” she says. “That has made him extremely
good at fundraising because he can talk to people about supporting the University
and the donors feel that they have a partner in the University.” Chobanian
will have a “stabilizing influence” on BU, according to Ullian.
Milestones
in Chobanian’s career include his founding of the Whitaker Cardiovascular
Institute at BU in 1973, leading the National Institutes of Health–funded
Specialized Center of Research in Hypertension from 1975 to 1995, and chairing
a panel this year that developed new national guidelines for hypertension. The
author of more than 250 articles and two books and the recipient of numerous
awards, he received his bachelor’s degree from Brown University and his
M.D. from Harvard Medical School.
Chobanian sent a letter to the BU community
on October 31 saying that during
his tenure, “my focus will be on our schools and colleges, our faculty
and staff, and most importantly, our students. I have spent 40 years as a member
of the Boston University community, which I have come to love, respect, and admire.
I will do everything possible to support this institution and the people who
have made it the outstanding university it is today.”
University holiday on November 17
Although inaugural activities planned for later this month have
been canceled, BU President ad interim Aram Chobanian, in a November
4 e-mail to faculty, staff, and students, announced that November
17 will remain a University holiday according to the schedule established
within each school and department.
“ Over the next few days,” wrote Chobanian, “the Office of
the Dean of Students will announce a program of student activities, including
community service opportunities. I hope you find the day productive.”
|
|
 |